» Articles » PMID: 32674928

Review Of: "Hydroxychloroquine and Azithromycin As a Treatment of COVID-19: Results of an Open-label Non-randomized Clinical Trial Gautret Et Al 2010, DOI:10.1016/j.ijantimicag.2020.105949

Overview
Date 2020 Jul 18
PMID 32674928
Citations 30
Authors
Affiliations
Soon will be listed here.
Citing Articles

COVID-19 drug discovery and treatment options.

Chan J, Yuan S, Chu H, Sridhar S, Yuen K Nat Rev Microbiol. 2024; 22(7):391-407.

PMID: 38622352 DOI: 10.1038/s41579-024-01036-y.


Impact of the COVID-19 pandemic on community antibiotic consumption in the EU/European Economic Area: a changepoint analysis.

Vermeulen H, Hens N, Catteau L, Catry B, Coenen S J Antimicrob Chemother. 2023; 78(10):2572-2580.

PMID: 37671788 PMC: 10545522. DOI: 10.1093/jac/dkad273.


Raising concerns on questionable ethics approvals - a case study of 456 trials from the Institut Hospitalo-Universitaire Méditerranée Infection.

Frank F, Florens N, Meyerowitz-Katz G, Barriere J, Billy E, Saada V Res Integr Peer Rev. 2023; 8(1):9.

PMID: 37533089 PMC: 10398994. DOI: 10.1186/s41073-023-00134-4.


COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery.

Kumar S, Basu M, Ghosh P, Pal U, Ghosh M Genes Dis. 2023; 10(4):1402-1428.

PMID: 37334160 PMC: 10079314. DOI: 10.1016/j.gendis.2022.12.019.


Hydroxychloroquine and COVID-19: The endgame!.

Deplanque D Therapie. 2023; 78(4):343-344.

PMID: 37321943 PMC: 10246298. DOI: 10.1016/j.therap.2023.06.003.